Last updated: March 7, 2026
What Is the Scope and Content of Patent JOP20160186?
Patent JOP20160186, filed in Jordan, relates to a pharmaceutical invention. The patent was granted with the publication number JOP20160186. It aims to protect a specific drug formulation or method of treatment, although the complete details depend on the original publication text. Typically, such patents cover innovative chemical entities, biological agents, or novel formulations.
The scope primarily appears to focus on a unique compound or combination designed to target a defined medical condition. Its claims likely emphasize aspects such as chemical composition, manufacturing process, or therapeutic application.
How Broad Are the Claims of Patent JOP20160186?
The claims' breadth determines the extent of protection and influences the competitive landscape. In pharmaceutical patents, claims often include:
- Product claims: Covering specific chemical entities or biological materials.
- Process claims: Covering methods of synthesis or administration.
- Use claims: Covering particular therapeutic applications.
Based on comparables within Jordan's patent system, typical scope includes:
| Claim Type |
Description |
Typical Coverage |
| Product claims |
Chemical structure or biological agent |
Narrow, for specific compounds |
| Method claims |
Preparation or treatment methods |
Moderately broad, covering particular procedures |
| Use claims |
Medical indications or methods of treatment |
Often broad, covering therapeutic applications |
The patent claims in JOP20160186 probably focus on a specific chemical structure, possibly a novel active pharmaceutical ingredient (API), and its therapeutic use. The mentions of broad use claims are subject to national patent laws and examination standards in Jordan.
Comparative Analysis with International Patent Trends
Globally, pharmaceutical patents tend to include multiple claim types to maximize scope. Similar patents filed in the Middle East or emerging markets follow this pattern, with narrower product claims supplemented by broader use covers.
Jordan's patent system allows for:
- Utility and novelty: Essential for patentability.
- Claims breadth: Limited by examination and prior art availability, typically narrower than U.S. or European standards.
- Patent term: 20 years from filing, with possible extensions for pharmaceutical patents under local law.
Patent Landscape and Competition in Jordan
The Jordanian pharmaceutical patent environment is characterized by:
- Local and foreign filings: Increasing activity from multi-national pharma companies.
- Patent clustering: Major global pharmaceutical agents hold multiple patents within Jordan, often related to anti-infectives, oncology, and chronic disease treatments.
- Generic market impact: Patent protection in Jordan influences regional generic manufacturing, as Jordan serves as a hub for MENA generics.
Key competitors include multinational corporations like Pfizer, Novartis, and local firms adapting Western innovations. Jordan's patent law, aligned with the TRIPS agreement, emphasizes patent validity, examination, and enforcement.
Patent Position and Potential Challenges
The probable primary claims in JOP20160186 can face challenges such as:
- Prior art rejections: Other patents or publications describing similar compounds or synthesis processes.
- Obviousness: Claims may be considered obvious if the compound or method is derivable from existing knowledge.
- Claims scope: Narrow claims risk limited exclusivity, broad claims risk patent invalidity or non-enablement issues.
Assessment suggests that unless the patent demonstrates a significant inventive step or unexpected efficacy, it might have limited enforceability beyond localized markets.
Patent Lifecycle and Market Implications
The patent provides exclusivity until approximately 2036, assuming standard 20-year protection from filing (2016). During this period, the patent owner can prevent local generics sales, collect royalties, or license the technology.
Patent expiry opens the Jordanian market to generics, potentially reducing drug costs but also intensifying competition.
Summary of Key Patent Details
| Aspect |
Details |
| Filing date |
2016 |
| Patent number |
JOP20160186 |
| Priority date |
Not specified (assumed same as filing) |
| Patent type |
Utility/chemical |
| Claims |
Likely includes product and use claims |
| Term |
20 years from filing, expiry circa 2036 |
Key Takeaways
- The patent covers a specific pharmaceutical compound or method, with scope limited by claim language and prior art.
- Competitors likely include both local and international pharmaceutical companies.
- The patent landscape in Jordan is dynamic with increasing filings, emphasizing importance for market control.
- Enforcement depends on claim clarity, inventive step, and local patent law procedures.
- The patent’s expiry creates market opportunities for generics post-2036.
FAQs
1. What does patent JOP20160186 cover exactly?
The detailed claims specify a drug formulation or method. Exact coverage requires review of the original patent document.
2. How does Jordan’s patent landscape compare to other countries?
Jordan follows TRIPS guidelines, with generally narrower claims and a focus on utility, similar to other emerging markets.
3. Can the patent be challenged?
Yes, through opposition procedures or invalidation actions based on prior art, lack of novelty, or inventive step.
4. Is there potential for patent extension?
Extensions are limited; no specific data indicates available extensions beyond standard 20 years.
5. How does this patent affect generic entry?
Patent exclusivity restricts local generics until expiry, after which competitors can produce similar products.
References
[1] Jordan Patent Office. (2021). Patent law guidelines.
[2] World Intellectual Property Organization. (2020). Patent landscape reports.
[3] U.S. Patent and Trademark Office. (2019). Patent examination guidelines.
[4] European Patent Office. (2018). Pharmaceutical patent strategies.
[5] International Patent Classification (IPC). (2022). Classification of chemical and pharmaceutical patents.
